These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
984 related articles for article (PubMed ID: 28282270)
21. The success of fecal microbial transplantation in Park H; Laffin MR; Jovel J; Millan B; Hyun JE; Hotte N; Kao D; Madsen KL Gut Microbes; 2019; 10(6):676-687. PubMed ID: 30866714 [No Abstract] [Full Text] [Related]
22. Efficacy of combined jejunal and colonic fecal microbiota transplantation for recurrent Clostridium difficile Infection. Dutta SK; Girotra M; Garg S; Dutta A; von Rosenvinge EC; Maddox C; Song Y; Bartlett JG; Vinayek R; Fricke WF Clin Gastroenterol Hepatol; 2014 Sep; 12(9):1572-6. PubMed ID: 24440222 [TBL] [Abstract][Full Text] [Related]
23. One dog's waste is another dog's wealth: A pilot study of fecal microbiota transplantation in dogs with acute hemorrhagic diarrhea syndrome. Gal A; Barko PC; Biggs PJ; Gedye KR; Midwinter AC; Williams DA; Burchell RK; Pazzi P PLoS One; 2021; 16(4):e0250344. PubMed ID: 33872339 [TBL] [Abstract][Full Text] [Related]
24. Effectiveness of fecal-derived microbiota transfer using orally administered capsules for recurrent Clostridium difficile infection. Hirsch BE; Saraiya N; Poeth K; Schwartz RM; Epstein ME; Honig G BMC Infect Dis; 2015 Apr; 15():191. PubMed ID: 25885020 [TBL] [Abstract][Full Text] [Related]
27. Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease. Khanna S; Vazquez-Baeza Y; González A; Weiss S; Schmidt B; Muñiz-Pedrogo DA; Rainey JF; Kammer P; Nelson H; Sadowsky M; Khoruts A; Farrugia SL; Knight R; Pardi DS; Kashyap PC Microbiome; 2017 May; 5(1):55. PubMed ID: 28506317 [TBL] [Abstract][Full Text] [Related]
28. Safety and preliminary efficacy of orally administered lyophilized fecal microbiota product compared with frozen product given by enema for recurrent Clostridium difficile infection: A randomized clinical trial. Jiang ZD; Jenq RR; Ajami NJ; Petrosino JF; Alexander AA; Ke S; Iqbal T; DuPont AW; Muldrew K; Shi Y; Peterson C; Do KA; DuPont HL PLoS One; 2018; 13(11):e0205064. PubMed ID: 30388112 [TBL] [Abstract][Full Text] [Related]
29. Alteration of gut microbial composition associated with the therapeutic efficacy of fecal microbiota transplantation in Clostridium difficile infection. Lee PC; Chang TE; Wang YP; Lee KC; Lin YT; Chiou JJ; Huang CW; Yang UC; Li FY; Huang HC; Wu CY; Huang YH; Hou MC J Formos Med Assoc; 2022 Sep; 121(9):1636-1646. PubMed ID: 34836663 [TBL] [Abstract][Full Text] [Related]
30. Faecal microbiota transplantation for recurrent Clostridioides difficile infection: experience with lyophilized oral capsules. Reigadas E; Bouza E; Olmedo M; Vázquez-Cuesta S; Villar-Gómara L; Alcalá L; Marín M; Rodríguez-Fernández S; Valerio M; Muñoz P J Hosp Infect; 2020 Jun; 105(2):319-324. PubMed ID: 31883938 [TBL] [Abstract][Full Text] [Related]
31. Depletion of butyrate-producing microbes of the Firmicutes predicts nonresponse to FMT therapy in patients with recurrent Tian H; Cui J; Ye C; Zhao J; Yang B; Xu Y; Ji S; Wang L; Lv X; Ma C; Zhou S; Li N; Wang X; Qin H; Chen Q Gut Microbes; 2023; 15(1):2236362. PubMed ID: 37469017 [TBL] [Abstract][Full Text] [Related]
32. Restoration of short chain fatty acid and bile acid metabolism following fecal microbiota transplantation in patients with recurrent Clostridium difficile infection. Seekatz AM; Theriot CM; Rao K; Chang YM; Freeman AE; Kao JY; Young VB Anaerobe; 2018 Oct; 53():64-73. PubMed ID: 29654837 [TBL] [Abstract][Full Text] [Related]
34. Freeze-dried fecal samples are biologically active after long-lasting storage and suited to fecal microbiota transplantation in a preclinical murine model of Reygner J; Charrueau C; Delannoy J; Mayeur C; Robert V; Cuinat C; Meylheuc T; Mauras A; Augustin J; Nicolis I; Modoux M; Joly F; Waligora-Dupriet AJ; Thomas M; Kapel N Gut Microbes; 2020 Sep; 11(5):1405-1422. PubMed ID: 32501140 [TBL] [Abstract][Full Text] [Related]
35. Effective fecal microbiota transplantation for recurrent Clostridioides difficile infection in humans is associated with increased signalling in the bile acid-farnesoid X receptor-fibroblast growth factor pathway. Monaghan T; Mullish BH; Patterson J; Wong GK; Marchesi JR; Xu H; Jilani T; Kao D Gut Microbes; 2019; 10(2):142-148. PubMed ID: 30183484 [TBL] [Abstract][Full Text] [Related]
36. Microbiome changes associated with sustained eradication of Clostridium difficile after single faecal microbiota transplantation in children with and without inflammatory bowel disease. Hourigan SK; Chen LA; Grigoryan Z; Laroche G; Weidner M; Sears CL; Oliva-Hemker M Aliment Pharmacol Ther; 2015 Sep; 42(6):741-52. PubMed ID: 26198180 [TBL] [Abstract][Full Text] [Related]
37. Effectiveness and Safety of Colonic and Capsule Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection. Vaughn BP; Fischer M; Kelly CR; Allegretti JR; Graiziger C; Thomas J; McClure E; Kabage AJ; Khoruts A Clin Gastroenterol Hepatol; 2023 May; 21(5):1330-1337.e2. PubMed ID: 36126907 [TBL] [Abstract][Full Text] [Related]
38. Gut fungal dysbiosis correlates with reduced efficacy of fecal microbiota transplantation in Clostridium difficile infection. Zuo T; Wong SH; Cheung CP; Lam K; Lui R; Cheung K; Zhang F; Tang W; Ching JYL; Wu JCY; Chan PKS; Sung JJY; Yu J; Chan FKL; Ng SC Nat Commun; 2018 Sep; 9(1):3663. PubMed ID: 30202057 [TBL] [Abstract][Full Text] [Related]